Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Heidi HensonExecutive Employment Agreement • March 12th, 2018 • Kura Oncology, Inc. • Pharmaceutical preparations • California
This Amended and Restated Executive Employment Agreement (the “Agreement”), entered into between Kura Oncology, Inc. (the “Company”) and Heidi Henson (the “Executive”) (collectively, the “Parties”), is effective as of January 29, 2016 (the “Effective Date”). As of the Effective Date, this Agreement amends, restates and supersedes in its entirety the Executive Employment previously entered into by the Parties on October 1, 2014 and amended on May 12, 2015 (together, the “Prior Agreement”).
VIA CERTIFIED MAILKura Oncology, Inc. • March 12th, 2018 • Pharmaceutical preparations
Pursuant to Section 8.2 of the Research Agreement, we hereby give notice of the exercise by Kura of its option to obtain an exclusive royalty-bearing license to the University’s interest in the patent application numbered […***…]. Effective upon this notice, the Patent License Agreement between the University and Kura is deemed amended (Amendment 6) to add the above-referenced patent application to subsection (ii)(a) of the definition of PATENT RIGHTS under such agreement.
